Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
JAMA Ophthalmology
|
November 2, 2018
Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis
Leisha A Emens, S Lindsey Davis, Scott C N Oliver, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2020
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer
Martin Reck, Thomas Wehler, Francisco Orlandi, et al.
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
The Journal of Molecular Diagnostics : JMD
|
June 17, 2023
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology
Maria E Arcila, Utsav Patel, Amir Momeni-Boroujeni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2018
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Louis Fehrenbacher, Joachim von Pawel, Keunchil Park, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
JAMA Ophthalmology
|
November 2, 2018
Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis
Leisha A Emens, S Lindsey Davis, Scott C N Oliver, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2020
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer
Martin Reck, Thomas Wehler, Francisco Orlandi, et al.
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
The Journal of Molecular Diagnostics : JMD
|
June 17, 2023
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology
Maria E Arcila, Utsav Patel, Amir Momeni-Boroujeni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 20, 2018
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Louis Fehrenbacher, Joachim von Pawel, Keunchil Park, et al.
Page
of 3